UniSuper Management Pty Ltd Acquires 10,379 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

UniSuper Management Pty Ltd raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 34.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,492 shares of the company's stock after buying an additional 10,379 shares during the quarter. UniSuper Management Pty Ltd's holdings in GE HealthCare Technologies were worth $3,166,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the stock. CoreFirst Bank & Trust bought a new position in GE HealthCare Technologies during the fourth quarter valued at $25,000. Runnymede Capital Advisors Inc. purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at about $28,000. Continuum Advisory LLC lifted its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares during the last quarter. Bank of Jackson Hole Trust purchased a new position in GE HealthCare Technologies in the fourth quarter worth about $32,000. Finally, OFI Invest Asset Management bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 11.1 %

GEHC stock traded down $8.78 during mid-day trading on Thursday, reaching $70.58. The company had a trading volume of 3,285,484 shares, compared to its average volume of 2,945,350. The company has a market capitalization of $32.28 billion, a PE ratio of 16.30, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The firm has a 50 day moving average of $86.30 and a 200 day moving average of $85.71. GE HealthCare Technologies Inc. has a 12 month low of $70.49 and a 12 month high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.20%. GE HealthCare Technologies's payout ratio is currently 3.23%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $97.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.